Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.07Cr 1.92Cr 1.77Cr 3.34Cr 226.12Cr 3.41Cr 23Cr 8.97Cr 111.04Cr 8.87Cr 8.68Cr 383.48Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.7Cr 3.43Cr 3.15Cr 5.96Cr 403.76Cr 6.08Cr 41Cr 16Cr 198.28Cr 16Cr 15Cr 684.75Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-20.71%-19.80% - - 13.34L
+1.76%-4.61%+53.68%+608.85% 264.57Cr
+3.59%+0.51% - - 195.21Cr
+1.70%-1.96%+139.53%+800.83% 170.88Cr
+1.11%-12.92%-41.67%-63.82% 163.72Cr
+2.66%+3.41%-36.38%+34.49% 117.16Cr
+0.49%-0.83%+292.13%+926.92% 111.48Cr
+0.67%+1.06%+51.26%+37.15% 95Cr
+4.80%-8.14%+51.36%+63.68% 83Cr
+3.26%-1.77%-42.04%-90.02% 42Cr
Average -0.06%-2.11%+58.48%+289.76% 138.01Cr
Weighted average by Cap. +2.10%-2.33%+63.90%+382.01%

Financials

2015 2016
Net sales 2.55Cr 2.23Cr 2.07Cr 1.9Cr 3.6Cr 243.89Cr 3.67Cr 25Cr 9.68Cr 119.77Cr 9.57Cr 9.36Cr 413.62Cr 3.23Cr 2.84Cr 2.63Cr 2.42Cr 4.57Cr 309.43Cr 4.66Cr 31Cr 12Cr 151.96Cr 12Cr 12Cr 524.78Cr
Net income 54.95L 48.19L 44.64L 41.07L 77.68L 53Cr 79.2L 5.32Cr 2.09Cr 26Cr 2.06Cr 2.02Cr 89Cr 20.61L 18.08L 16.74L 15.41L 29.14L 20Cr 29.71L 2Cr 78.27L 9.69Cr 77.4L 75.71L 33Cr
Net Debt 2.48Cr 2.18Cr 2.02Cr 1.85Cr 3.51Cr 237.41Cr 3.58Cr 24Cr 9.42Cr 116.59Cr 9.31Cr 9.11Cr 402.63Cr 1.86Cr 1.63Cr 1.51Cr 1.39Cr 2.62Cr 177.64Cr 2.68Cr 18Cr 7.05Cr 87Cr 6.97Cr 6.82Cr 301.27Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-